ArticleBMJ open2017

Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study.

Jean-David Zeitoun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.